71650
磷酸钠 二元 十二水合物
puriss. p.a., crystallized, ≥99.0% (T)
别名:
磷酸氢二钠, 磷酸氢二钠 十二水合物
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
Na2HPO4 · 12H2O
化学文摘社编号:
分子量:
358.14
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12161700
EC Number:
231-448-7
MDL number:
Assay:
≥99.0% (T)
Form:
crystals
Solubility:
water: soluble 35.8 g/L at 20 °C
grade
puriss. p.a.
Quality Level
assay
≥99.0% (T)
form
crystals
quality
crystallized
pH
9.0-9.3 (25 °C, 50 mg/mL in H2O)
solubility
water: soluble 35.8 g/L at 20 °C
anion traces
chloride (Cl-): ≤5 mg/kg, fluoride (F-): ≤5 mg/kg, sulfate (SO42-): ≤50 mg/kg
cation traces
As: ≤0.5 mg/kg, Ca: ≤10 mg/kg, Cd: ≤5 mg/kg, Co: ≤5 mg/kg, Cr: ≤5 mg/kg, Cu: ≤5 mg/kg, Fe: ≤5 mg/kg, K: ≤50 mg/kg, Mg: ≤5 mg/kg, Mn: ≤5 mg/kg, Ni: ≤5 mg/kg, Pb: ≤5 mg/kg, Zn: ≤5 mg/kg
SMILES string
O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].OP([O-])([O-])=O
InChI
1S/2Na.H3O4P.12H2O/c;;1-5(2,3)4;;;;;;;;;;;;/h;;(H3,1,2,3,4);12*1H2/q2*+1;;;;;;;;;;;;;/p-2
InChI key
DGLRDKLJZLEJCY-UHFFFAOYSA-L
General description
磷酸钠是无色结晶钠盐。它被广泛用作分子生物学、生物化学和色谱研究的缓冲液。它以三种形式存在：一元（NaH2PO4）、二元（Na2HPO4）和三元（Na3PO4）。中性磷酸钠缓冲溶液通常由不同比例的一元和二元形式的磷酸钠制备而成。
Application
磷酸氢二钠十二水合物可用于制备 0.1M 磷酸盐缓冲液（pH 7.4）。
Still not finding the right product?
Explore all of our products under 磷酸钠 二元 十二水合物
存储类别
13 - Non Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Chia Lin Chang et al.
Evidence-based complementary and alternative medicine : eCAM, 2012, 125247-125247 (2011-07-15)
The objectives of this study were to determine phytochemical compositions, chemiluminescence antioxidant activities, and neuroprotective effects on PC12 cells for water, methanol, and 95% ethanol extracts of the air-dried fruit of Terminalia chebula Retzius. The water extract afforded the greatest
Matthew H Crouthamel et al.
Arteriosclerosis, thrombosis, and vascular biology, 33(11), 2625-2632 (2013-08-24)
Elevated serum phosphate has emerged as a major risk factor for vascular calcification. The sodium-dependent phosphate cotransporter, PiT-1, was previously shown to be required for phosphate-induced osteogenic differentiation and calcification of cultured human vascular smooth muscle cells (VSMCs), but its
Matthew R Weir et al.
Journal of clinical hypertension (Greenwich, Conn.), 16(12), 875-882 (2014-10-21)
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure (BP) and osmotic diuresis- and intravascular volume reduction-related adverse events (AEs) were evaluated using pooled data from four placebo-controlled, phase 3 studies in patients with type 2
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 71650-1KG | 04061835563616 |